Trial Profile
Feasibility of Dexmedetomidine-based Sedation in Neurocritical Care Patients : a Pilot Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam; Propofol
- Indications Traumatic brain injuries
- Focus Adverse reactions
- 09 Oct 2014 New trial record